Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Feasibility of Antiretroviral Therapy With a Single Agent - Lopinavir/r - in Patients Treated With HAART and With Viral Load Below 80 Copies/Ml

NCT00160849 is registered in ClinicalTrials.gov with Universidade Federal do Rio de Janeiro as lead sponsor.

NCT NCT00160849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00160849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Feasibility of Antiretroviral Therapy With a Single Agent - Lopinavir/r - in Patients Treated With HAART and With Viral Load Below 80 Copies/Ml
Lead sponsor
Universidade Federal do Rio de Janeiro
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2004
Completion date
March 31, 2007
Enrollment
60
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections